More recently, EphB4 expression was correlated with differentiation, lymph node metastasis and TNM stage in 28 NSCLC patients, while the polymorphism in EphB4 at rs314310 appeared to correspond to protein expression and disease susceptibility[35]. The gene discussed is EPHB4; the disease is metastatic malignant neoplasm in the lymph nodes.